Featured Research

from universities, journals, and other organizations

Standard IVF medication dose less effective in obese women

Date:
March 20, 2014
Source:
Endocrine Society
Summary:
Obese women may need a different dose of medication than normal weight women in order to successfully have their eggs harvested for in vitro fertilization (IVF), according to a new study. IVF is a type of assisted reproductive technology used to help women become pregnant. More than 1 percent of all infants born in the United States each year are conceived using assisted reproductive technology.

Obese women may need a different dose of medication than normal weight women in order to successfully have their eggs harvested for in vitro fertilization (IVF), according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

IVF is a type of assisted reproductive technology used to help women become pregnant. More than 1 percent of all infants born in the United States each year are conceived using assisted reproductive technology, according to the U.S. Centers for Disease Control and Prevention.

IVF involves mixing sperm with an egg outside the body and then transferring the resulting embryo into the uterus. The goal is to harvest many eggs to ensure a successful IVF cycle. As part of the egg harvesting process, women receive a medication called a GnRH antagonist to prevent the brain from giving the ovulation signal too early and ruining the egg harvest.

"If the GnRH antagonist clears from a woman's body too quickly, there is a risk that the brain will signal the body to discharge the eggs from the ovaries too early," said one of the study's authors, Nanette Santoro, MD, of the University of Colorado at Denver. "We were surprised to find obese women were more likely to experience this, and it may be one reason why overweight and obese women have a higher rate of unsuccessful IVF cycles than normal weight women do."

The interventional study examined the rate of medication absorption in 10 obese and 10 normal-weight women. Researchers gave each participant a dose of a GnRH antagonist used in IVF procedures. To determine how quickly the medication was absorbed, the participants had their blood frequently sampled for six hours, beginning eight hours after the medication was first administered.

The study found the GnRH antagonist cleared out of the obese women's systems more quickly than the normal-weight women. In addition, half of the obese women had a rebound of luteinizing hormone -- the hormone that causes the body to release eggs -- during the 14-hour monitoring period.

"Our findings indicate obese women may need a different or increased dosing regimen to improve fertility treatment outcomes," Santoro said. "Given the cost of IVF and stress of infertility, it is important to maximize each woman's chances of conceiving a child."


Story Source:

The above story is based on materials provided by Endocrine Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lauren W. Roth, Erica L. Bradshaw-Pierce, Amanda A. Allshouse, Jennifer Lesh, Justin Chosich, Andrew P. Bradford, Alex J. Polotsky, Nanette Santoro. Evidence of GnRH Antagonist Escape in Obese Women. The Journal of Clinical Endocrinology & Metabolism, 2014; jc.2013-3598 DOI: 10.1210/jc.2013-3598

Cite This Page:

Endocrine Society. "Standard IVF medication dose less effective in obese women." ScienceDaily. ScienceDaily, 20 March 2014. <www.sciencedaily.com/releases/2014/03/140320134720.htm>.
Endocrine Society. (2014, March 20). Standard IVF medication dose less effective in obese women. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/03/140320134720.htm
Endocrine Society. "Standard IVF medication dose less effective in obese women." ScienceDaily. www.sciencedaily.com/releases/2014/03/140320134720.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins